Venom immunotherapy;Hyposensibilisierung der hymenopterengiftallergie

Wiener Medizinische Wochenschrift

Volumn 149, Issue 14-15, 1999, Pages 421-428

  Przybilla, B ^a   Ruëff, Franziska ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Hymenoptera venom allergy; Immunotherapy

Indexed keywords

BEE VENOM; IMMUNOGLOBULIN E; WASP VENOM;

ALLERGY; ANAPHYLAXIS; BEE STING; CLINICAL PROTOCOL; DESENSITIZATION; HUMAN; HYMENOPTERA; IMMUNOTHERAPY; NONHUMAN; REVIEW; SKIN TEST; SYMPTOMATOLOGY;

ANAPHYLAXIS; ANIMALS; BEE VENOMS; DESENSITIZATION, IMMUNOLOGIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYMENOPTERA; HYPERSENSITIVITY, IMMEDIATE; INSECT BITES AND STINGS; MONITORING, IMMUNOLOGIC; WASP VENOMS;

EID: 0032754616     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. (1) Bauer CP: Stichprovokation zur Diagnostik von Insektengift-Allergien? Allergologie 1986;9:S14.
2. (2) Bäurle G, Schwarz W: Hymenopterengift-Allergie. Stellenwert des allergenspezifischen IgG bei der Therapie. Dtsch Med Wschr 1983;108:1351-1355.
3. (3) Benson RL, Semenov H: Allergy in its relation to bee sting. J Allergy 1930;1:105-116.
4. (4) Berchtold E, Maibach R, Müller U: Reduction of side effects from rush immunotherapy with honey-bee venom by pretreatment with terfenadine. Clin Exp Allergy 1992;22:59-65.
5. (5) Bousquet J, Ménardo JL, Velasquez G, Michel FB: Systemic reactions during maintenance immunotherapy with honey bee venom. Ann Allergy 1988;61:63-68.
6. (6) Bresser H, Sandner C, Rakoski J: Insektenstichnotfälle in München 1992. Allergo J 1992;4:373-376.
7. (7) Brockow K, Kiehn M, Riethmüller C, Vieluf D, Berger J, Ring J: Efficacy of antihistamine treatment in the prevention of adverse reactions to Hymenoptera immunotherapy: A prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1997;100: 458-463.
8. (8) Chipps BE, Valentine MD, Kagey-Sobotka A, Schuberth KC, Lichtenstein LM: Diagnosis and treatment of anaphylactic reactions to Hymenoptera stings in children. J Pediatr 1980;97:177-184.
9. (9) Committee on Insects: Position statement. The discontinuation of Hymenoptera venom immunotherapy. J Allergy Clin Immunol 1998;101:573-575.
10. (10) Ewan PW, Deighton J, Wilson AB, Lachmann PJ: Venom-specific IgG antibodies in bee and wasp allergy: Lack of correlation with protection from stings. Clin Exp Allergy 1993;23:647-660.
11. (11) Franken HH, Dubois AEJ, Minkema HJ, van der Heide S, de Monchy JGR: Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity. J Allergy Clin Immunol 1994;93:431-436.
12. (12) Goldberg A. Confino-Cohen R: Timing of venom skin tests and IgE determinations after insect sting anaphylaxis. J Allergy Clin Immunol 1997;100:182-184.
13. (13) Golden DBK, Kagey-Sobotka A, Valentine MD, Lichtenstein LM: Dose-dependence of Hymenoptera venom immunotherapy. J Allergy Clin Immunol 1981;67:370-374.
14. (14) Golden DBK, Kwiterovich KA, Kagey-Sobotka A, Valentine MD, Lichtenstein LM: Discontinuing venom immunotherapy (VIT): determinants of clinical reactivity. J Allergy Clin Immunol 1989;83:273.
15. (15) Golden DBK, Langlois J, Valentine MD, Kagey-Sobotka A, Lichtenstein LM: Treatment failures with whole-body extract therapy of insect sting allergy. J Am Med Ass 1981:246:2460-2463.
16. (16) Golden DBK, Valentine MD, Kagey-Sobotka A, Lichtenstein LM: Prevalence of hymenoptera venom allergy. J Allergy Clin Immunol 1982;69:124.
17. (17) Harries MG, Kemeny DM, Youlten LJF, McK Mills M, Lessof MH: Skin and radioallergosorbent test in patients with sensitivity to bee and wasp venom. Clin Allergy 1984;14:407-412.
18. (18) Haugaard L, Norregaard OFH, Dahl R: In-hospilal sting challenge in insect venom-allergic patients after stopping venom immunotherapy. J Allergy Clin Immunol 1991;87:699-702.
19. (19) Hoffman DR, Gillman SA, Cummins LH, Kozak PP, Oswald A: Correlation of IgG and IgE antibody levels to honeybee venom allergens with protection to sting challenge. Ann Allergy 1981;46:17-23.
20. (20) Hunt KJ, Valentine MD, Sobotka AK. Benton AW. Amodio FJ, Lichtenstein LM: A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978;299:157-161.
21. (21) Jessberger B, Habig J, Karl S, Rakoski J: Hymenopterengiftallergie: Hyposensibilisienrungstherapie trotz vorhandener Kontraindikationen. Allergologie 1994;17:255-260.
22. (22) Kampelmacher MJ, van der Zwan JC: Provocation test with a living insect as a diagnostic: tool in systemic reactions to bee and wasp venom: A prospective study with emphasis on the clinical aspects. Clin Allergy 1987;17:317-327.
23. (23) Keating MU, Kagey-Sobotka A, Hamilton RG, Yunginger JW; Clinical and immunologic follow-up of patients who stop venom immunotherapy. J Allergy Clin Immunol 1991;88:339-348.
24. (24) Lerch E, Müller UR: Long-term protection after stopping venom immunotherapy: Results of re-stings in 200 patients. J Allergy Clin Immunol 1998;101:606-612.
25. (25) Lotter G: Sensibilisierung für Bienengift durch Typhus-Antitoxin und Desensibilisicrung mit Forapin. Münch Med Wschr 1939;86:330-331.
26. (26) Loveless MH, Fackler WR: Wasp venom allergy and immunity. Ann Allergy 1956;14:347-366.
27. (27) Mailing HJ, Weeke D (eds); Position paper: Immunotherapy. Allergy 1993;48 (suppl 14): 9-35.
28. (28) Müller UR: Insektenstichallergie. Klinik, Diagnostik und Therapie. Stuttgart. Fischer, 1988.
29. (29) Müller U, Berchtold E, Helbling A: Honeybee venom allergy: Results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients. J Allergy Clin Immunol 1991;87: 702-709.
30. (30) Müller U, Helbling A, Berthold E: Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol 1992;89:529-535.
31. (31) Müller UR, Helbling A. Bischof M: Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honeybee venom. Allergy 1989;44:412-418.
32. (32) Müller U, Mosbech H (eds); Position paper: Immunotherapy with Hymenoptera venoms. Allergy 1993;48 (suppl 14): 37-46.
33. (33) Müller U, Mosbech H, Blauww P, Dreborg S, Mailing HJ, Przybilla B, Urbanek R, Pastorello E, Blanca M, Bousquet J, Jarisch R, Youlten L: Emergency treatment of allergic reactions to hymenoptera stings. Clin Exp Allergy 1991;21:281-288.
34. (34) Nataf P, Guinnepain MT, Herman D: Rush venom immunotherapy: A 3-day program for hymenoptera sting allergy. Clin Allergy 1984;14:269-275.
35. (35) Przybilla B: Insektengift-Allergie, Akt Dermatol 1998;24: 382-387.
36. (36) Przybilla B, Ring J: Hymenoptera venom allergy. In Ring J. Prxybilla B (eds): New Trends in Allergy III. Berlin-Heidelberg New York, Springer, 1991, pp 335-349.
37. (37) Przybilla B, Ring J, Gricsshammer B: Diagnostische Befunde bei Hymenopterengiftallergic, Zur Bedeutung von Anamnese, Hauttest und RAST. Allergologie 1989;12:192-202.
38. (38) Przybilla B, Ring J. Gricsshammer B: Association of features of atopy and diagnostic parameters in Hymenoptera venom allergy. Allergy 1991;46:570-576.
39. (39) Przybilla B, Ring J, Griesshammer B, Braun-Falco O: Schnell-hyposensibilisierung mit Hymenopterengiften, Verträglichkeit und Therapieerfolg. Dtsch Med Wschr 1987;112:416-424.
40. (40) Przybilla B, Ring J, Rieger B: Die Indikation zur Hymenopteren-gift Hyposensibilisierung kann nicht anhand eines diagnostische Parameter bewertenden Punkteschemas gestellt werden. Allergologie 1992;15:114-119.
41. (41) Reisman RE, Livingston A: Late onset allergic reactions, including serum sickness, after insect stings. J Allergy Clin Immunol 1989;84:331-337.
42. (42) Ring J, Messmer K: Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977;1:466-469.
43. (43) Ruëff F, Bollessen M, Przybilla B: Efficacy and safety of honeybee venom (HBV) immunotherapy with an aqueous (AE) and an aluminium hydroxide adsorbed depot extract (DE). Allergy 1998;43 (supp143): 208.
44. (44) Ruëff F, Przybilla B, Müller U, Mosbech H: The sting challenge test in Hymenoptera venom allergy. Allergy 1996;51:216-225.
45. (45) Ruëff F, Reißig J, Przybilla B: Nebenwirkungen der Schnellhy-posensibilisterung mil Hymenoplerengift. Allergo J 1997;6 (suppl 1): S59-S564.
46. (46) Rzany B, Przybilla B, Jarisch R, Aberer W, Dietschl R Wüthrich B, Bühler B. Frosch P, Rakoski J, Kiehn H, Kuhn W, Urbanek R, Ring J: Clinical characteristics of patients with repeated systemic reactions during specific immunotherapy with Hymenoptera venoms. A retrospective study. Allergy 1991:46:251-254.
47. (47) Schäfer T, Przybilla B: IgE antibodies to Hymenoptera venoms are common in the general population and are related to indications of atopy. Allergy 1996;51:372-377.
48. (48) Schumacher MJ, Tveten MS, Egen NB: Rate and quantity of delivery of venom from honeybee stings. J Allergy Clin Immunol 1994;93:831-835.
49. (49) Schwartz, HJ, Sutheimer C, Gauerke MB, Yunginger JW: Hymenoptera venom-specific IgE antibodies in post-mortem sera from victims of sudden, unexpected death. Clin Allergy 1988;18:461-468.
50. (50) Stapel SO, Waanders-Lijster de Raadt J, van Toorenenbergen AW, de Groot H (1998) Allergy to bumblebee venom, II, IgE cross-re-activity between bumblebee and honeybee venom. Allergy 1998;53: 769-777.
51. (51) Urbanek R, Forster J, Kuhn W, Ziupa J: Discontinuation of bee venom immunotherapy in children and adolescents. J Pediatr 1985;107:367-371.
52. (52) Valentine MD, Schuberth KC, Kagey-Sobotka A, Graft DF, Kwiterovich KA, Szklo M, Lichtenstein LM: The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med 1990;323:1601-1603.